Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgit Fogal

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Regulatory Toxicology and Pharmacology : RTP|April 20, 2024
Challenges and gaps in immunosafety evaluation of therapeutics: An IQ DruSafe surveyMark Collinge, Haley Neff-LaFord, Surekha Akella, et al.
Frontiers in Immunology|August 27, 2025
An explorable model of an adverse outcome pathway of cytokine release syndrome related to the administration of immunomodulatory biotherapeutics and cellular therapiesAlexander Mazein, Oxana Lopata, Kristin Reiche, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 5, 2011
Reperfusion injury intensifies the adaptive human T cell alloresponse in a human-mouse chimeric artery modelTai Yi, Birgit Fogal, Zhengrong Hao, et al.
Mabs|January 12, 2020
VHH antibody targeting the chemokine receptor CX3CR1 inhibits progression of atherosclerosisSarah Low, Haixia Wu, Kavita Jerath, et al.
Molecular Therapy. Methods & Clinical Development|January 26, 2023
Nonclinical pharmacokinetics and biodistribution of VSV-GP using methods to decouple input drug disposition and viral replicationRichard Dambra, Andrea Matter, Kaitlynn Graca, et al.
Journal of Immunotoxicology|December 10, 2024
Novel strategies to assess cytokine release mediated by chimeric antigen receptor T cells based on the adverse outcome pathway conceptMiriam Alb, Kristin Reiche, Michael Rade, et al.
Bioconjugate Chemistry|July 2, 2025
Tailoring the Methods of Conjugation and Characterization for a Replication-Competent, Live, Viral VectorElise Ishida, Richard Dambra, Sally Ye, et al.
Mabs|July 8, 2025
Impact of antibody Fc engineering on translational pharmacology, and safety: insights from industry case studiesFrank R Brennan, J Ryan Polli, Jean Sathish, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Regulatory Toxicology and Pharmacology : RTP|April 20, 2024
Challenges and gaps in immunosafety evaluation of therapeutics: An IQ DruSafe surveyMark Collinge, Haley Neff-LaFord, Surekha Akella, et al.
Frontiers in Immunology|August 27, 2025
An explorable model of an adverse outcome pathway of cytokine release syndrome related to the administration of immunomodulatory biotherapeutics and cellular therapiesAlexander Mazein, Oxana Lopata, Kristin Reiche, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 5, 2011
Reperfusion injury intensifies the adaptive human T cell alloresponse in a human-mouse chimeric artery modelTai Yi, Birgit Fogal, Zhengrong Hao, et al.
Mabs|January 12, 2020
VHH antibody targeting the chemokine receptor CX3CR1 inhibits progression of atherosclerosisSarah Low, Haixia Wu, Kavita Jerath, et al.
Molecular Therapy. Methods & Clinical Development|January 26, 2023
Nonclinical pharmacokinetics and biodistribution of VSV-GP using methods to decouple input drug disposition and viral replicationRichard Dambra, Andrea Matter, Kaitlynn Graca, et al.
Journal of Immunotoxicology|December 10, 2024
Novel strategies to assess cytokine release mediated by chimeric antigen receptor T cells based on the adverse outcome pathway conceptMiriam Alb, Kristin Reiche, Michael Rade, et al.
Bioconjugate Chemistry|July 2, 2025
Tailoring the Methods of Conjugation and Characterization for a Replication-Competent, Live, Viral VectorElise Ishida, Richard Dambra, Sally Ye, et al.
Mabs|July 8, 2025
Impact of antibody Fc engineering on translational pharmacology, and safety: insights from industry case studiesFrank R Brennan, J Ryan Polli, Jean Sathish, et al.
Pageof 2